2019 annual financial data
Foghorn Therapeutics 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -51,084,000 USD and net income was -51,128,000 USD.
Operating cash flow was -46,335,000 USD.
Get free Foghorn Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -51,084,000 USD
- Net income
- -51,128,000 USD
- Operating cash flow
- -46,335,000 USD